This resource is no longer available
Pharmaceutical companies report that their top challenge today is the increasing complexity of the operating environment, which has led to a decline in R&D efficiency.
In response, many pharma leaders are assessing their supply chain strategy and ultimately implementing digitally enabled supply chains that:
- Provide end-to-end visibility and collaboration capabilities
- Drive risk assessment
- Enable synergy assessments and value capture in mergers and acquisitions
Explore this white paper to gain insight into the state of the pharma supply chain industry and how GEP’s supply chain platform can support the growing needs of pharmaceutical companies.